Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2022 | Story Rulanzen Martin | Photo Sonia Small (Kaleidoscope Studios)
Dr Munyaradzi Mushonga is very optimistic about his appointment as the Global Academic Director of the Decolonial International Network.

Dr Munyaradzi Mushonga of the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS) has been appointed Global Academic Director of the Decolonial International Network (DIN). Dr Mushonga, who is a senior lecturer and programme director of CGAS’s Africa Studies programme, says his vision for DIN is “to work towards a new world civilisation that is opposed to the militarism and war, lawlessness and genocides of other civilisations.” 

Dr Mushonga, who is a leading voice and scholar on decolonialisation, will formally assume his role at DIN in 2023. 

The duality of new technology and scholarly work

Dr Mushonga says it is important for our minds to be decolonised, and he is therefore planning to establish a Centre for Decolonising The Mind (CDTM), which will use 21st-century technologies to achieve the ideal of decolonialisation. “Here pluriversal decolonial chapters and centres will be driven towards developing a decolonial history app,” he says. The aim is also to work towards a decolonial textbook on the history of Africa. 

He says it is commendable to employ technology to address decolonisation, but the real work to achieve the ideal of a decolonial mind lies in the scholarly work done by academics. At the CGAS the entire Africa Studies programme addresses decolonial theory and praxis through several approaches. “These are informed by our identity, which is anchored on two pillars, namely the interdisciplinary nature of all our engagements, as well as the exploration and critique of what it means to be ‘human’, but also in relation to the ‘non-human’ world.” He adds that the Centre’s teaching, supervision, and engagement with its students also challenges academics to think beyond the binaries of ‘coloniser’ and ‘colonised’, ‘white’ and ‘black’, and to reject all forms of fundamentalism. 

UFS’s commitment to decoloniality is a great asset 

Dr Mushonga's tenure at DIN will also reinforce the commitment to decolonial education made by the UFS, which has been noted by DIN. “I am convinced that DIN, the CGAS and the UFS can become the great vehicles to drive the decolonial agenda from the global South in general, and South Africa in particular,” he says. He says the commitment to the ideals of decolonisation displayed by UFS and the CGAS played a large part in his appointment to his new DIN role. 

The CGAS and the UFS will become key players in the DIN project, and Dr Mushonga hopes that more individuals and groups will come forward to join forces with DIN. “I hope this will enable DIN to push for new ethics in living.” 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept